riociguatBPACochrane CENTRAL
…marker improvements over riociguat in inoperable CTEPH, whereas riociguat enhances cardiac output. A patient-specific approach considerin…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…marker improvements over riociguat in inoperable CTEPH, whereas riociguat enhances cardiac output. A patient-specific approach considerin…
…th mPAP ≤30 mmHg and ≤25 mmHg conferring the best prognosis for BPA and PEA-treated patients, respectively. These data should encou…